World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
57
Citations
11297
World Ranking
3631
National Ranking
86

François Spertini publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where François Spertini sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 292 publications — 62nd percentile

62% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

François Spertini D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where François Spertini sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 57 D-Index — 28th percentile

28% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

François Spertini is affiliated with the University Hospital of Lausanne in Switzerland. Their research predominantly lies within the field of Medicine, with a particular focus on Immunology and Allergy, Pathology and Forensic Medicine, Dermatology, and Infectious Diseases.

The scientist's work covers a range of topics primarily related to immune and allergic responses. The main topics of their research include:

  • Allergic Rhinitis and Sensitization
  • Systemic Sclerosis and Related Diseases
  • Asthma and Respiratory Diseases
  • Dermatology and Skin Diseases
  • Dermatologic Treatments and Research
  • Inflammatory Myopathies and Dermatomyositis
  • Mast Cells and Histamine

Frequent publication venues for François Spertini's studies include:

  • Lara D. Veeken
  • Frontiers in Immunology
  • Allergologie select
  • Allergo Journal
  • Allergologie

The scientist has contributed to several recent papers, including:

  • Treatment of allergic rhinitis during and outside the pollen season using mobile technology. A MASK study (2020), Clinical and Translational Allergy
  • Cytokine-directed therapy with tocilizumab for immune checkpoint inhibitor-related hemophagocytic lymphohistiocytosis (2020), Annals of Oncology
  • Phenotype of limited cutaneous systemic sclerosis patients with positive anti-topoisomerase I antibodies: data from the EUSTAR cohort (2022), Lara D. Veeken
  • Use of biologicals in allergic and type-2 inflammatory diseases during the current COVID-19 pandemic (2020), Allergologie select
  • Safety and immunogenicity of a synthetic nanoparticle-based, T cell priming peptide vaccine against dengue in healthy adults in Switzerland: a double-blind, randomized, vehicle-controlled, phase 1 study (2023), EBioMedicine

Frequent collaborators in François Spertini's research include:

  • Valeria Riccieri
  • Ana Maria Gheorghiu
  • Elise Siegert
  • Marie Vanthuyne
  • Paloma García de la Peña Lefebvre

Best Publications

  • Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance.

    Filipe Martins;Filipe Martins;Latifyan Sofiya;Gerasimos P. Sykiotis;Faiza Lamine

  • Open-label, multicentre, dose-escalating phase II clinical trial on the safety and efficacy of tadekinig alfa (IL-18BP) in adult-onset Still's disease

    Cem Gabay;Bruno Fautrel;Jürgen Rech;François Spertini

  • Research needs in allergy: an EAACI position paper, in collaboration with EFA

    Nikolaos G Papadopoulos;Ioana Agache;Sevim Bavbek;Beatrice M Bilo

  • MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis

    Jean Bousquet;Holger J. Schünemann;Peter W. Hellings;Sylvie Arnavielhe

  • Allergen-specific T-cell tolerance induction with allergen-derived long synthetic peptides: Results of a phase I trial

    Jean-Marc Fellrath;Alexander Kettner;Nathalie Dufour;Christian Frigerio

  • Phase I malaria vaccine trial with a long synthetic peptide derived from the merozoite surface protein 3 antigen

    Régine Audran;Régine Audran;Michel Cachat;Floriana Lurati;Soe Soe

  • A malaria vaccine that elicits in humans antibodies able to kill Plasmodium falciparum.

    Pierre Druilhe;François Spertini;Daw Soesoe;Giampietro Corradin

  • CXCR3 Internalization Following T Cell-Endothelial Cell Contact: Preferential Role of IFN-Inducible T Cell α Chemoattractant (CXCL11)

    Alain Sauty;Richard A. Colvin;Ludwig Wagner;Sophie Rochat

  • Targeting of Secretory IgA to Peyer’s Patch Dendritic and T Cells after Transport by Intestinal M Cells

    Jacques Rey;Nathalie Garin;François Spertini;Blaise Corthésy

  • Safety of human immunisation with a live-attenuated Mycobacterium tuberculosis vaccine: a randomised, double-blind, controlled phase I trial.

    François Spertini;Régine Audran;Reza Chakour;Olfa Karoui

  • Elevated serum levels of free interleukin-18 in adult-onset Still’s disease

    Charlotte Girard;Jürgen Rech;Michael Brown;Danièle Allali

  • New therapeutic perspectives to manage refractory immune checkpoint-related toxicities.

    Filipe Martins;Filipe Martins;Gerasimos P Sykiotis;Michel Maillard;Montserrat Fraga

  • Down-regulation of interferon signature in systemic lupus erythematosus patients by active immunization with interferon α–kinoid†

    Bernard R. Lauwerys;Eric Hachulla;François Spertini;Estibaliz Lazaro

  • Safety and immunogenicity of a chimpanzee adenovirus-vectored Ebola vaccine in healthy adults: a randomised, double-blind, placebo-controlled, dose-finding, phase 1/2a study

    Olga De Santis;Régine Audran;Emilie Pothin;Loane Warpelin-Decrausaz

  • Cryoglobulinemia induced by a murine IgG3 rheumatoid factor: skin vasculitis and glomerulonephritis arise from distinct pathogenic mechanisms

    Luc Reininger;Thierry Berney;Takanori Shibata;Francois Spertini

  • A synthetic malaria vaccine elicits a potent CD8(+) and CD4(+) T lymphocyte immune response in humans. Implications for vaccination strategies.

    José Alejandro López;Christophe Weilenman;Régine Audran;Mario A. Roggero

  • EAACI IG Biologicals task force paper on the use of biologic agents in allergic disorders.

    O Boyman;C Kaegi;M Akdis;S Bavbek

  • Secretory IgA Possesses Intrinsic Modulatory Properties Stimulating Mucosal and Systemic Immune Responses

    Laurent Favre;François Spertini;Blaise Corthésy

  • Is diet partly responsible for differences in COVID-19 death rates between and within countries?

    Jean Bousquet;Josep M Anto;Guido Iaccarino;Wienczyslawa Czarlewski

  • Immune responses induced by lower airway mucosal immunisation with a human papillomavirus type 16 virus-like particle vaccine.

    Denise Nardelli-Haefliger;Floriana Lurati;Daniel Wirthner;François Spertini

Frequent Co-Authors

Giampietro Corradin
Giampietro Corradin University of Lausanne
Peter Schmid-Grendelmeier
Peter Schmid-Grendelmeier University of Zurich
Margitta Worm
Margitta Worm Charité - University Medicine Berlin
Blaise Corthésy
Blaise Corthésy University Hospital of Lausanne
Jean Bousquet
Jean Bousquet University of Montpellier
Marek Jutel
Marek Jutel Wrocław Medical University
Cezmi A. Akdis
Cezmi A. Akdis University of Zurich
Jorg Dieter Seebach
Jorg Dieter Seebach University of Geneva
Thomas Keil
Thomas Keil University of Würzburg
Ludger Klimek
Ludger Klimek Ghent University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in immunology often intersects with healthcare pathways, especially in nursing and specialized care roles. For individuals looking to fast-track their clinical expertise, exploring accelerated NP programs can be a vital step. These programs allow students to transition quickly from RN to Nurse Practitioner roles, broadening their clinical competencies.

For those beginning their journey without a prior nursing background, enrolling in online accelerated nursing programs for non nurses offers a flexible and efficient pathway into the nursing field. This approach is ideal for career changers eager to move into healthcare without extended on-campus commitments.

Once in the nursing profession, advancing to specialized roles such as acute care requires specific certifications. The acute care NP certification equips nurse practitioners with the skills necessary to handle complex patient care in hospital settings, a crucial competency for immunology-related healthcare roles.

Additionally, many students seek the easiest ABSN to get into to obtain their Bachelor of Science in Nursing quickly and begin practical experience. This can be a strategic choice for those aiming to integrate immunology knowledge with foundational nursing skills efficiently.

Best Scientists Citing François Spertini

Trending Scientists

Recently Published Articles